by Matt Foor | May 10, 2012
Pearl Pathways continues to see an increase in its national exposure. PharmaVOICE has featured Pearl Pathways twice in the last year. In the January PharmaVOICE article titled “Commercialization to Repertoire”, Pearl Pathways president and CEO, Diana...
by Matt Foor | May 3, 2012
Please join us for the quarterly InSPN Meeting being held on Thursday, May 10th from 8:00AM-1:30PM at One America Tower. Main topics include: Indiana Health Information Exchange- status of operations and security and Social Media Issues in the Workplace. To...
by Matt Foor | May 3, 2012
Please join us for the IHIF Annual Meeting on Monday, May 7 and Tuesday, May 8. IHIF will release its 2011 Annual Report and present the Statewide Strategic Plan for Indiana’s Health Science Sector. Pearl will have 3 or 4 teammates on hand so be sure to look...
by Matt Foor | May 1, 2012
A map has been released to display the locations of all FDA cGMP (Current Good Manufacturing Practice) warning letters issued in fiscal 2011. It is evident that the FDA is continuing its crackdown on overseas manufacturing plants as warning letters increased by 40%...
by Matt Foor | Apr 25, 2012
The European Medicines Agency (EMA) has released draft guidelines regarding continuous process verification (CPV) to bring its policies in line with ICH Q8, Q9, and Q10. The goal is to gain information a manufacturer can use to make adjustments during production to...
